Abstract
Retinoids and vitamin D are known to exert important anti-tumour effects in a variety of cell types. In this study the effects of 9-cis-retinoic acid (9cRA) the vitamin D analogues EB1089 and CB1093 on three pancreatic adenocarcinoma cell lines were investigated. All compounds caused inhibition of in vitro growth but the vitamin D analogues were generally the more potent growth inhibitors. They were also more effective on their own than in combination with 9cRA. Growth arrest correlated with an increased proportion of cells in the G0/G1 phase. Apoptosis was induced in the three cell lines by 9cRA, whereas neither EB1089 nor CB1093 had this effect. Furthermore, addition of EB1089 or CB1093 together with 9cRA resulted in significantly reduced apoptosis. Our results show that retinoic acids as well as vitamin D analogues have inhibitory effects on pancreatic tumour cells but different and antagonistic mechanisms seem to be employed. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bold RJ, Ishizuka J, Townsend CMJ and Thompson JC (1996) All-trans-retinoic acid inhibits growth of human pancreatic cancer cell lines. Pancreas 12: 189–195
Bollag W, Majewski S and Jablonska S (1994) Cancer combination chemotherapy with retinoids: experimental rationale. Leukemia 8: 1453–1457
Chen WH, Horoszewicz JS, Leong SS, Shimano T, Penetrante T, Sanders WH, Berjian R, Douglass HO, Martin EW and Ming Chu T (1982) Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. in vitro 18: 24–34
Colston KW (1997) Vitamin D and breast cancer: therapeutic potential of new vitamin D analogues. Vitamin D, Feldman D (ed), pp. 1107–1123, Academic Press: San Diego
Colston KW, James SJ, Ofori-Kuragu EA, Binderup L and Grant AG (1997) Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 76: 1017
Danielsson C, Mathiasen IS, James SJ, Nayeri S, Bretting C, Hansen CM, Colston KW and Carlberg C (1997) Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. J Cell Biochem 66: 552–562
Danielsson C, Torma H, Vahlquist A and Carlberg C (2000) Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis. Int J Cancer 81: 467–470
Dippold W, Bernhard H, Meyer zum B and schenfelde KH (1997) Chemotherapy in advanced pancreatic cancer. Int J Pancreatol 21: 39–41
El-Deriny S, O’Brien MJ, Christensen TG and Kupchik HZ (1987) Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells. Pancreas 2: 25–33
Elstner E, Campbell MJ, Munker R, Shintaku P, Binderup L, Heber D, Said J and Koeffler HP (2000) Novel 20-epi-vitamin D analog combined with 9- cis -retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate 40: 141–149
Evans RM (1998) The steroid and thyroid hormone receptor superfamily. Science 240: 889–895
Evans TRJ, Lofts FJ, Mansi JL, Glees JP, Dalgleish AG and Knight MJ (1996) A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer. Br J Cancer 73: 1260–1264
Gansauge S, Gansauge F and Beger HG (1996) Molecular oncology in pancreatic cancer. J Mol Med 74: 313–320
Gartel AL and Tyner AL (2000) Transcriptional regulation of the p21(WAF1/CIP1)gene. Exp Cell Res 246: 280–289
Giguere V, Ong ES, Segui P and Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330: 624–629
Haussler MR, Jurutka PW, Hsieh J-C, Thompson PD, Selznick SH, Haussler CA and Whitfield GK (1995) New understanding of the molecular mechanisms of receptor-mediated genomic actions of the vitamin D hormone. Bone 17: 33S–38S
Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE and Jurutka PW (1998) The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Min Res 13: 325–342
Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397–406
James SY, Mackay AG and Colston KW (1995) Vitamin D derivatives in combination with 9-cis-retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol 14: 391–394
James SY, Mercer E, Brady M Binderup L and Colston KW (1998) EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br J Pharmacol 125: 953–962
James SY, Williams MA, Newland AC and Colston KW (2000) Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol 32: 143–154
Kaiser A, Wolf-Breitinger M, Albers A, Dorbic T, Wittig B, Riecken EO and Rosewicz S (1998) Retinoic acid receptor gamma-1 expression determines retinoid sensitivity in pancreatic carcinoma cells. Gastroenterology 115: 967–977
Kane KF, Langman MJS and Williams GR (1996) Antiproliferative responses of two human colon cancer cell lines to vitamin D3 are differentially modified by 9-cis-retinoic acid. Cancer Res 56: 623–632
Kawa S, Yoshizawa K, Tokoo M, Imai H, Oguchi H, Kiyosawa K, Homma T, Nikaido T and Furihata K (1996) Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines. Gastroenterology 110: 1605–1613
Kawa S, Nikaido T, Zhai Y, Kumagai T, Furihata K, Fujii S and Kiyosawa K (1997) Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer 76: 884–889
Kliewer SA, Umesono K, Mangelsdorf DJ and Evans RM (1992) Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355: 446–449
Korsmeyer SJ (2000) BCL-2 gene family and the regulation of programmed cell death. Cancer Res 59: 1693s–1700s
Koshizuka K, Kubota T, Said J, Koike M, Binderup L, Uskokovic M and Koeffler HP (2000) Combination therapy of a vitamin D analog and all-trans-retinoic acid: effect on human breast cancer in nude mice. Anticancer Res 19: 519–524
Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck G, Kratzeisen C, Rosenberger M & Lovey A Grippo JF (1992) 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355: 359–361
Liu M, Lee M-H, Cohen M, Bommakanti M and Freedman LP (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142–153
Lotan R (1996) Retinoids in cancer chemoprevention. Faseb J 10: 1031–1039
Louvet C, Djelloul S, Forgue-Lafitte ME, Mester J, Zimber A and Gespach C (1996) Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-alpha. Br J Cancer 74: 394–399
Mathiasen IS, Colston KW and Binderup L (1993) EB1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol 46: 365–371
Matsumoto T, Sowa Y, Ohtani-Fujita N, Tamaki T, Takenaka T, Kuribayashi K and Sakai T (1998) p53-independent induction of WAF1/Cip1 is correlated with osteoblastic differentiation by vitamin D3. Cancer Lett 129: 61–68
Nagy L, Thomazy VA, Heyman RA and Davies PJ (1998) Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ 5: 11–19
Okabe T, Yamaguchi N and Oshawa N (1983) Establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the exocrine pancreas. Cancer 51: 662–668
Petkovich M, Brand NJ, Krust A and Chambon P (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330: 444–450
Philpott NJ, Turner AJ, Scopes J, Westby M, Marsh JC, Gordon-Smith EC, Dalgleish AG and Gibson AG (1996) The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 87: 2244–2251
Rosewicz S and Wiedenmann B (1997) Pancreatic carcinoma. Lancet 349: 485–489
Rosewicz S, Stier U, Brembeck F, Wiedenmann B and Riecken EO (1995) Retinoids: effect on growth, differentiation and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 109: 1646–1660
Rothenberg ML, Moore MJ, Cripps MC, Andersen,, Portenoy RK, Burris HA, Green MR, Tarassoff PG, Brown TD, Casper ES, Stornioli AM and Von Hoff DD (1996) A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 7: 247–253
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesh H, Kenney S and Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107–1112
Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian R, Douglass HD and Chu TM (1986) Characterization of a new primary human pancreatic tumour line. Cancer Invest 4: 15–23
Wang QM, Jones JB and Studzinski GP (1996) Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 56: 264–267
Wang X and Studzinski GP (1997) Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp Cell Res 235: 210–217
Zugmaier G, Jager R, Grage B, Gottardis MM, Havemann K and Knabbe C (1996) Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer 73: 1341–1346
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Pettersson, F., Colston, K. & Dalgleish, A. Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro. Br J Cancer 83, 239–245 (2000). https://doi.org/10.1054/bjoc.2000.1281
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1281
Keywords
This article is cited by
-
The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies
European Journal of Nutrition (2024)
-
Environmental risk factors for pancreatic cancer: an update
Archives of Toxicology (2016)
-
Synergistic effect of retinoic acid and vitamin D analog EB1089-induced apoptosis of hepatocellular cancer cells
Cytotechnology (2013)
-
Furano-sesquiterpene from soft coral, Sinularia kavarittiensis: induces apoptosis via the mitochondrial-mediated caspase-dependent pathway in THP-1, leukemia cell line
Apoptosis (2009)
-
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer
Investigational New Drugs (2009)